| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stroke, Vol 22, 983-988, Copyright © 1991 by American Heart Association
PA Wolf, RD Abbott and WB Kannel
The impact of nonrheumatic atrial fibrillation, hypertension, coronary
heart disease, and cardiac failure on stroke incidence was examined in
5,070 participants in the Framingham Study after 34 years of follow-up.
Compared with subjects free of these conditions, the age-adjusted incidence
of stroke was more than doubled in the presence of coronary heart disease
(p less than 0.001) and more than trebled in the presence of hypertension
(p less than 0.001). There was a more than fourfold excess of stroke in
subjects with cardiac failure (p less than 0.001) and a near fivefold
excess when atrial fibrillation was present (p less than 0.001). In persons
with coronary heart disease or cardiac failure, atrial fibrillation doubled
the stroke risk in men and trebled the risk in women. With increasing age
the effects of hypertension, coronary heart disease, and cardiac failure on
the risk of stroke became progressively weaker (p less than 0.05).
Advancing age, however, did not reduce the significant impact of atrial
fibrillation. For persons aged 80-89 years, atrial fibrillation was the
sole cardiovascular condition to exert an independent effect on stroke
incidence (p less than 0.001). The attributable risk of stroke for all
cardiovascular contributors decreased with age except for atrial
fibrillation, for which the attributable risk increased significantly (p
less than 0.01), rising from 1.5% for those aged 50-59 years to 23.5% for
those aged 80- 89 years. While these findings highlight the impact of each
cardiovascular condition on the risk of stroke, the data suggest that the
elderly are particularly vulnerable to stroke when atrial fibrillation is
present.(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study
Department of Neurology, Evans Memorial Department of Clinical Research, Boston, Mass.
This article has been cited by other articles:
 |
|
 |
|
  J. Qi, J. Xiao, Y. Zhang, J. Li, Y. Liu, P. Li, L. Liang, B. Jiang, W. Wen, C. Zhao, et al. Effects of Potassium Channel Blockers on Changes in Refractoriness of Atrial Cardiomyocytes Induced by Stretch Experimental Biology and Medicine, July 1, 2009; 234(7): 779 - 784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Crandall, D. J. Bradley, D. L. Packer, and S. J. Asirvatham Contemporary Management of Atrial Fibrillation: Update on Anticoagulation and Invasive Management Strategies Mayo Clin. Proc., July 1, 2009; 84(7): 643 - 662. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 The ACTIVE Investigators Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation N. Engl. J. Med., May 14, 2009; 360(20): 2066 - 2078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Uretsky, A. Shah, S. Bangalore, L. Rosenberg, R. Sarji, D. R. Cantales, D. Macmillan-Marotti, F. A. Chaudhry, and M. V. Sherrid Assessment of left atrial appendage function with transthoracic tissue Doppler echocardiography Eur J Echocardiogr, May 1, 2009; 10(3): 363 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 The European Registers of Stroke (EROS) Investigat Incidence of Stroke in Europe at the Beginning of the 21st Century Stroke, May 1, 2009; 40(5): 1557 - 1563. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Conen, U. B. Tedrow, B. A. Koplan, R. J. Glynn, J. E. Buring, and C. M. Albert Influence of Systolic and Diastolic Blood Pressure on the Risk of Incident Atrial Fibrillation in Women Circulation, April 28, 2009; 119(16): 2146 - 2152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The GISSI-AF Investigators Valsartan for Prevention of Recurrent Atrial Fibrillation N. Engl. J. Med., April 16, 2009; 360(16): 1606 - 1617. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Ad, S. D. Barnett, C. K. Haan, S. M. O'Brien, S. Milford-Beland, and A. M. Speir Does preoperative atrial fibrillation increase the risk for mortality and morbidity after coronary artery bypass grafting? J. Thorac. Cardiovasc. Surg., April 1, 2009; 137(4): 901 - 906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kaab, D. Darbar, C. van Noord, J. Dupuis, A. Pfeufer, C. Newton-Cheh, R. Schnabel, S. Makino, M. F. Sinner, P. J. Kannankeril, et al. Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation Eur. Heart J., April 1, 2009; 30(7): 813 - 819. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nabauer, A. Gerth, T. Limbourg, S. Schneider, M. Oeff, P. Kirchhof, A. Goette, T. Lewalter, U. Ravens, T. Meinertz, et al. The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management Europace, April 1, 2009; 11(4): 423 - 434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. van Walraven, R. G. Hart, S. Connolly, P. C. Austin, J. Mant, F.D. R. Hobbs, P. J. Koudstaal, P. Petersen, F. Perez-Gomez, J. A. Knottnerus, et al. Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation: The Atrial Fibrillation Investigators Stroke, April 1, 2009; 40(4): 1410 - 1416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Z. Soliman, R. J. Prineas, L. D. Case, Z.-m. Zhang, and D. C. Goff Jr Ethnic Distribution of ECG Predictors of Atrial Fibrillation and Its Impact on Understanding the Ethnic Distribution of Ischemic Stroke in the Atherosclerosis Risk in Communities (ARIC) Study Stroke, April 1, 2009; 40(4): 1204 - 1211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Go, M. C. Fang, N. Udaltsova, Y. Chang, N. K. Pomernacki, L. Borowsky, D. E. Singer, and for the ATRIA Study Investigators Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study Circulation, March 17, 2009; 119(10): 1363 - 1369. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. H. Tay, D. A. Lane, and G. Y. H. Lip Challenges facing anticoagulation among the elderly and frail Age Ageing, March 1, 2009; 38(2): 140 - 142. [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Bailey, D. C. Scantlebury, and S. S. Smyth Thrombosis and Antithrombotic Therapy in Women Arterioscler. Thromb. Vasc. Biol., March 1, 2009; 29(3): 284 - 288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Fatema, M. E. Barnes, K. R. Bailey, W. P. Abhayaratna, S. Cha, J. B. Seward, and T. S.M. Tsang Minimum vs. maximum left atrial volume for prediction of first atrial fibrillation or flutter in an elderly cohort: a prospective study Eur J Echocardiogr, March 1, 2009; 10(2): 282 - 286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E.B. Balbao, A. A.V. de Paola, and G. Fenelon Effects of alcohol on atrial fibrillation: myths and truths Therapeutic Advances in Cardiovascular Disease, February 1, 2009; 3(1): 53 - 63. [Abstract] [PDF]
|
|
|
|
|
|
L. Friberg, N. Hammar, and M. Rosenqvist Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation Eur. Heart J., January 27, 2009; (2009) ehn599v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Bejot, D. B. Salem, G. V. Osseby, G. Couvreur, J. Durier, C. Marie, Y. Cottin, T. Moreau, and M. Giroud Epidemiology of ischemic stroke from atrial fibrillation in Dijon, France, from 1985 to 2006 Neurology, January 27, 2009; 72(4): 346 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
WRITING GROUP MEMBERS, D. Lloyd-Jones, R. Adams, M. Carnethon, G. De Simone, T. B. Ferguson, K. Flegal, E. Ford, K. Furie, A. Go, et al. Heart Disease and Stroke Statistics--2009 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, January 27, 2009; 119(3): e21 - e181. [Full Text] [PDF]
|
|
|
|
 |
|
 F. Belluzzi, L. Sernesi, P. Preti, F. Salinaro, M. L. Fonte, and S. Perlini Prevention of recurrent lone atrial fibrillation by the angiotensin-II converting enzyme inhibitor ramipril in normotensive patients. J. Am. Coll. Cardiol., January 6, 2009; 53(1): 24 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Ricci, L. Morichelli, and M. Santini Remote control of implanted devices through Home MonitoringTM technology improves detection and clinical management of atrial fibrillation Europace, January 1, 2009; 11(1): 54 - 61. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. L. Mao, J. J. Wheeler, L. Clohs, G. N. Beatch, and J. Keirns Pharmacokinetics of Novel Atrial-Selective Antiarrhythmic Agent Vernakalant Hydrochloride Injection (RSD1235): Influence of CYP2D6 Expression and Other Factors J. Clin. Pharmacol., January 1, 2009; 49(1): 17 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bajpai, I. Savelieva, and A. J. Camm Treatment of atrial fibrillation Br. Med. Bull., December 5, 2008; (2008) ldn046v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Wachtell, R. B. Devereux, P. A. Lyle, P. M. Okin, and E. Gerdts The left atrium, atrial fibrillation, and the risk of stroke in hypertensive patients with left ventricular hypertrophy Therapeutic Advances in Cardiovascular Disease, December 1, 2008; 2(6): 507 - 513. [Abstract] [PDF]
|
|
|
|
 |
|
 For questions on page Emerg. Med. J., December 1, 2008; 25(12): 860 - 860. [Full Text] [PDF]
|
|
|
|
|
|
A. H. Tayal, M. Tian, K. M. Kelly, S. C. Jones, D. G. Wright, D. Singh, J. Jarouse, J. Brillman, S. Murali, and R. Gupta Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke Neurology, November 18, 2008; 71(21): 1696 - 1701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Heeringa, E. H. Hoogendoorn, W. M. van der Deure, A. Hofman, R. P. Peeters, W. C. J. Hop, M. den Heijer, T. J. Visser, and J. C. M. Witteman High-Normal Thyroid Function and Risk of Atrial Fibrillation: The Rotterdam Study Arch Intern Med, November 10, 2008; 168(20): 2219 - 2224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. H. Hauser, D. C. Peters, J. V. Wylie, and W. J. Manning Evaluating the left atrium by magnetic resonance imaging Europace, November 1, 2008; 10(suppl_3): iii22 - iii27. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Niinuma, R. T. George, A. Arbab-Zadeh, J. A.C. Lima, and C. A. Henrikson Imaging of pulmonary veins during catheter ablation for atrial fibrillation: the role of multi-slice computed tomography Europace, November 1, 2008; 10(suppl_3): iii14 - iii21. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Mariscalco, C. Klersy, M. Zanobini, M. Banach, S. Ferrarese, P. Borsani, C. Cantore, P. Biglioli, and A. Sala Atrial Fibrillation After Isolated Coronary Surgery Affects Late Survival Circulation, October 14, 2008; 118(16): 1612 - 1618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Salzberg, A. M. Gillinov, A. Anyanwu, J. Castillo, F. Filsoufi, and D. H. Adams Surgical left atrial appendage occlusion: evaluation of a novel device with magnetic resonance imaging Eur. J. Cardiothorac. Surg., October 1, 2008; 34(4): 766 - 770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Fumoto, A. M. Gillinov, Y. Ootaki, M. Akiyama, D. Saeed, T. Horai, C. Ootaki, D. G. Vince, Z. B. Popovic, R. Dessoffy, et al. A novel device for left atrial appendage exclusion: the third-generation atrial exclusion device. J. Thorac. Cardiovasc. Surg., October 1, 2008; 136(4): 1019 - 1027. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Adam, H.-R. Neuberger, M. Bohm, and U. Laufs Prevention of Atrial Fibrillation With 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Circulation, September 16, 2008; 118(12): 1285 - 1293. [Full Text] [PDF]
|
|
|
|
|
|
D. Hu and Y. Sun Epidemiology, Risk Factors for Stroke, and Management of Atrial Fibrillation in China J. Am. Coll. Cardiol., September 2, 2008; 52(10): 865 - 868. [Full Text] [PDF]
|
|
|
|
|
|
S. Knecht, C. Oelschlager, T. Duning, H. Lohmann, J. Albers, C. Stehling, W. Heindel, G. Breithardt, K. Berger, E. B. Ringelstein, et al. Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy Eur. Heart J., September 1, 2008; 29(17): 2125 - 2132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. L Bayard, S. H Ostermayer, and H. Sievert Alternatives to warfarin in atrial fibrillation: drugs and devices Heart, September 1, 2008; 94(9): 1113 - 1116. [Full Text] [PDF]
|
|
|
|
 |
|
 A M Veitch, T P Baglin, A H Gershlick, S M Harnden, R Tighe, and S Cairns Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures Gut, September 1, 2008; 57(9): 1322 - 1329. [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Camm and J. A. Reiffel Defining endpoints in clinical trials on atrial fibrillation Eur. Heart J. Suppl., September 1, 2008; 10(suppl_H): H55 - H78. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Aliot and J. N. Ruskin Controversies in ablation of atrial fibrillation Eur. Heart J. Suppl., September 1, 2008; 10(suppl_H): H32 - H54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Romero, J. Morris, and A. Pikula Review: Stroke prevention: modifying risk factors Therapeutic Advances in Cardiovascular Disease, August 1, 2008; 2(4): 287 - 303. [Abstract] [PDF]
|
|
|
|
 |
|
 I van Wijk, P J Koudstaal, L J Kappelle, J van Gijn, J W Gorter, A Algra, and for the LiLAC Study Group Long-term occurrence of death and cardiovascular events in patients with transient ischaemic attack or minor ischaemic stroke: comparison between arterial and cardiac source of the index event J. Neurol. Neurosurg. Psychiatry, August 1, 2008; 79(8): 895 - 899. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Tanaka, Y. Ishikawa, M. Yokoyama, H. Origasa, M. Matsuzaki, Y. Saito, Y. Matsuzawa, J. Sasaki, S. Oikawa, H. Hishida, et al. Reduction in the Recurrence of Stroke by Eicosapentaenoic Acid for Hypercholesterolemic Patients: Subanalysis of the JELIS Trial Stroke, July 1, 2008; 39(7): 2052 - 2058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Schneider, R. Malisius, K. Krause, F. Lampe, E. Bahlmann, S. Boczor, M. Antz, S. Ernst, and K.-H. Kuck Strain rate imaging for functional quantification of the left atrium: atrial deformation predicts the maintenance of sinus rhythm after catheter ablation of atrial fibrillation Eur. Heart J., June 1, 2008; 29(11): 1397 - 1409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. C. Ng, G. T. Altemose, Q. Wu, K. Srivathsan, and L. R. P. Scott Typical Atrial Flutter as a Risk Factor for the Development of Atrial Fibrillation in Patients Without Otherwise Demonstrable Atrial Tachyarrhythmias Mayo Clin. Proc., June 1, 2008; 83(6): 646 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Singer, G. W. Albers, J. E. Dalen, M. C. Fang, A. S. Go, J. L. Halperin, G. Y. H. Lip, and W. J. Manning Antithrombotic Therapy in Atrial Fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 546S - 592S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. D. Vagaonescu, A. C. Wilson, and J. B. Kostis Atrial Fibrillation and Isolated Systolic Hypertension: The Systolic Hypertension in the Elderly Program and Systolic Hypertension in the Elderly Program-Extension Study Hypertension, June 1, 2008; 51(6): 1552 - 1556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Darbar, P. J. Kannankeril, B. S. Donahue, G. Kucera, T. Stubblefield, J. L. Haines, A. L. George Jr, and D. M. Roden Cardiac Sodium Channel (SCN5A) Variants Associated with Atrial Fibrillation Circulation, April 15, 2008; 117(15): 1927 - 1935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Voeller, M. S. Bailey, A. Zierer, S. C. Lall, S.-i. Sakamoto, K. Aubuchon, J. S. Lawton, N. Moazami, C. B. Huddleston, N. A. Munfakh, et al. Isolating the entire posterior left atrium improves surgical outcomes after the Cox maze procedure. J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 870 - 877. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Aull-Watschinger, H. Konstantin, D. Demetriou, M. Schillinger, A. Habicht, W. H. Horl, and B. Watschinger Pre-transplant predictors of cerebrovascular events after kidney transplantation Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1429 - 1435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Stramba-Badiale Atrial fibrillation subtypes, risk of stroke, and antithrombotic therapy Eur. Heart J., April 1, 2008; 29(7): 840 - 842. [Full Text] [PDF]
|
|
|
|
 |
|
 C. L Garwood and T. L Corbett Use of Anticoagulation in Elderly Patients with Atrial Fibrillation Who Are at Risk for Falls Ann. Pharmacother., April 1, 2008; 42(4): 523 - 532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Watanabe, N. Tanabe, T. Watanabe, D. Darbar, D. M. Roden, S. Sasaki, and Y. Aizawa Metabolic Syndrome and Risk of Development of Atrial Fibrillation: The Niigata Preventive Medicine Study Circulation, March 11, 2008; 117(10): 1255 - 1260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Taimur and S. Hussaini Atrial fibrillation in a commercial diver Occup. Med., March 1, 2008; 58(2): 144 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Douen, N. Pageau, and S. Medic Serial Electrocardiographic Assessments Significantly Improve Detection of Atrial Fibrillation 2.6-Fold in Patients With Acute Stroke Stroke, February 1, 2008; 39(2): 480 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. B. Goldstein and P. M. Rothwell Advances in Prevention and Health Services Delivery 2007 Stroke, February 1, 2008; 39(2): 258 - 260. [Full Text] [PDF]
|
|
|
|
|
|
Writing Group Members, W. Rosamond, K. Flegal, K. Furie, A. Go, K. Greenlund, N. Haase, S. M. Hailpern, M. Ho, V. Howard, et al. Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, January 29, 2008; 117(4): e25 - e146. [Full Text] [PDF]
|
|
|
|
|
|
A. G.G. Turpie New oral anticoagulants in atrial fibrillation Eur. Heart J., January 2, 2008; 29(2): 155 - 165. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. E. Cohn, I. D. Gregoric, B. Radovancevic, R. K. Wolf, and O.H. Frazier Atrial Fibrillation After Cardiac Transplantation: Experience in 498 Consecutive Cases Ann. Thorac. Surg., January 1, 2008; 85(1): 56 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N.-H. Pan, H.-M. Tsao, N.-C. Chang, Y.-J. Chen, and S.-A. Chen Aging Dilates Atrium and Pulmonary Veins: Implications for the Genesis of Atrial Fibrillation Chest, January 1, 2008; 133(1): 190 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Voeller, R. B. Schuessler, and R. J. Damiano Jr. Surgical Treatment of Atrial Fibrillation Card. Surg. Adult, January 1, 2008; 3(2008): 1375 - 1394. [Full Text]
|
|
|
|
|
|
D. A. Lane and G. Y.H. Lip Barriers to Anticoagulation in Patients With Atrial Fibrillation: Changing Physician-Related Factors Stroke, January 1, 2008; 39(1): 7 - 9. [Full Text] [PDF]
|
|
|
|
|
|
M. B Nichol, T. K Knight, T. Dow, G. Wygant, G. Borok, O. Hauch, and R. O'Connor Quality of Anticoagulation Monitoring in Nonvalvular Atrial Fibrillation Patients: Comparison of Anticoagulation Clinic versus Usual Care Ann. Pharmacother., January 1, 2008; 42(1): 62 - 70. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Nutescu ASHP Therapeutic Position Statement on Antithrombotic Therapy in Chronic Atrial Fibrillation Am. J. Health Syst. Pharm., November 1, 2007; 64(21): 2281 - 2291. [Full Text] [PDF]
|
|
|
|
|
|
P. J. Barry, P. Gallagher, C. Ryan, and D. O'mahony START (screening tool to alert doctors to the right treatment) an evidence-based screening tool to detect prescribing omissions in elderly patients Age Ageing, November 1, 2007; 36(6): 632 - 638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Liao, Z. Khalid, C. Scallan, C. Morillo, and M. O'Donnell Noninvasive Cardiac Monitoring for Detecting Paroxysmal Atrial Fibrillation or Flutter After Acute Ischemic Stroke: A Systematic Review Stroke, November 1, 2007; 38(11): 2935 - 2940. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hughes, G.Y.H. Lip, and on behalf of the Guideline Development Group for t Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review QJM, October 1, 2007; 100(10): 599 - 607. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Yamashita, A. Sekiguchi, T. Kato, T. Tsuneda, Y.-k. Iwasaki, K. Sagara, H. Iinuma, H. Sawada, and T. Aizawa Angiotensin type 1 receptor blockade prevents endocardial dysfunction of rapidly paced atria in rats Journal of Renin-Angiotensin-Aldosterone System, September 1, 2007; 8(3): 127 - 132. [Abstract] [PDF]
|
|
|
|
|
|
L. Baruch, B. F. Gage, J. Horrow, S. Juul-Moller, A. Labovitz, M. Persson, and M. Zabalgoitia Can Patients at Elevated Risk of Stroke Treated With Anticoagulants Be Further Risk Stratified? Stroke, September 1, 2007; 38(9): 2459 - 2463. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A Fitzmaurice, F D R. Hobbs, S. Jowett, J. Mant, E. T Murray, R. Holder, J P Raftery, S Bryan, M. Davies, G. Y H Lip, et al. Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial BMJ, August 25, 2007; 335(7616): 383 - 383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Fatkin, R. Otway, and J. I. Vandenberg Genes and Atrial Fibrillation: A New Look at an Old Problem Circulation, August 14, 2007; 116(7): 782 - 792. [Full Text] [PDF]
|
|
|
|
|
|
Y. Miyasaka, M. E. Barnes, R. C. Petersen, S. S. Cha, K. R. Bailey, B. J. Gersh, G. Casaclang-Verzosa, W. P. Abhayaratna, J. B. Seward, T. Iwasaka, et al. Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a community-based cohort Eur. Heart J., August 2, 2007; 28(16): 1962 - 1967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Y.-J. Shen, J. F. Yao, S. S. Brar, M. B. Jorgensen, and W. Chen Racial/Ethnic Differences in the Risk of Intracranial Hemorrhage Among Patients With Atrial Fibrillation J. Am. Coll. Cardiol., July 24, 2007; 50(4): 309 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Damiano Jr and M. Bailey The Cox-Maze IV procedure for lone atrial fibrillation MMCTS, July 23, 2007; 2007(0723): 2758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Jahangir, V. Lee, P. A. Friedman, J. M. Trusty, D. O. Hodge, S. L. Kopecky, D. L. Packer, S. C. Hammill, W.-K. Shen, and B. J. Gersh Long-Term Progression and Outcomes With Aging in Patients With Lone Atrial Fibrillation: A 30-Year Follow-Up Study Circulation, June 19, 2007; 115(24): 3050 - 3056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. V. d. Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur. Heart J. Suppl., June 1, 2007; 9(suppl_C): C3 - C74. [Full Text] [PDF]
|
|
|
|
|
|
M. D. Gammage, J. V. Parle, R. L. Holder, L. M. Roberts, F. D. R. Hobbs, S. Wilson, M. C. Sheppard, and J. A. Franklyn Association Between Serum Free Thyroxine Concentration and Atrial Fibrillation Arch Intern Med, May 14, 2007; 167(9): 928 - 934. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Anderson, R. Fuller, and N. Dudley 'Rules of thumb' or reflective practice? Understanding senior physicians' decision-making about anti-thrombotic usage in atrial fibrillation QJM, May 1, 2007; 100(5): 263 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rastas, A. Verkkoniemi, T. Polvikoski, K. Juva, L. Niinisto, K. Mattila, E. Lansimies, T. Pirttila, and R. Sulkava Atrial Fibrillation, Stroke, and Cognition: A Longitudinal Population-Based Study of People Aged 85 and Older Stroke, May 1, 2007; 38(5): 1454 - 1460. [Abstract] [Full Text] [PDF]
|
|